Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease

Abstract The outcomes of patients with elderly onset (EO) inflammatory bowel disease (IBD) treated with anti-tumor necrosis factor (TNF) remains uncertain. The present study evaluated the efficacy and safety of anti-TNF treatment for bio-naïve EO-IBD. Elderly patients were defined as those 60 years...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Takahiro Amano, Shinichiro Shinzaki, Akiko Asakura, Taku Tashiro, Mizuki Tani, Yuriko Otake, Takeo Yoshihara, Shuko Iwatani, Takuya Yamada, Yuko Sakakibara, Naoto Osugi, Shuji Ishii, Satoshi Egawa, Manabu Araki, Yuki Arimoto, Masanori Nakahara, Yoko Murayama, Ichizo Kobayashi, Kazuo Kinoshita, Hiroyuki Ogawa, Satoshi Hiyama, Narihiro Shibukawa, Masato Komori, Yorihide Okuda, Takashi Kizu, Shunsuke Yoshii, Yoshiki Tsujii, Yoshito Hayashi, Takahiro Inoue, Hideki Iijima, Tetsuo Takehara
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2022-03-01
Sarja:	Scientific Reports
Linkit:	https://doi.org/10.1038/s41598-022-09455-8
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!